Opioid Use Disorder and Pregnancy

Mo Med. 2017 May-Jun;114(3):181-186.

Abstract

Over-prescription of opioid pain medications and increases in heroin use have contributed to the sharp rise in opioid-related hospitalizations and overdose deaths among young adults in the United States, including pregnant women. This has imposed substantial direct and indirect costs to our nation's health care system. Effective treatment with methadone and buprenorphine is available, but significant barriers to care may restrict access for many. Improved screening tools and expanded access to treatments for substance use disorders are keys to addressing the epidemic of opioid use disorder.

MeSH terms

  • Analgesics, Opioid / therapeutic use
  • Buprenorphine / administration & dosage
  • Buprenorphine / therapeutic use
  • Centers for Disease Control and Prevention, U.S. / economics
  • Cost of Illness
  • Drug Overdose / mortality*
  • Female
  • Hospitalization / statistics & numerical data
  • Humans
  • Methadone / administration & dosage
  • Methadone / therapeutic use
  • Missouri / epidemiology
  • Narcotic Antagonists / therapeutic use
  • Opiate Substitution Treatment / economics
  • Opiate Substitution Treatment / methods*
  • Opiate Substitution Treatment / statistics & numerical data
  • Opioid-Related Disorders / drug therapy
  • Opioid-Related Disorders / economics
  • Opioid-Related Disorders / epidemiology*
  • Pregnancy
  • Pregnancy Complications / chemically induced*
  • Pregnancy Complications / drug therapy
  • Pregnancy Complications / epidemiology
  • Prescription Drug Misuse / adverse effects
  • Prescription Drug Misuse / statistics & numerical data*
  • Substance Withdrawal Syndrome / epidemiology
  • United States / epidemiology

Substances

  • Analgesics, Opioid
  • Narcotic Antagonists
  • Buprenorphine
  • Methadone